Identification of Novel Neuraminidase Inhibitors as Potential Anti-Influenza Agents: Virtual Screening, Molecular Docking, in vitro Validation and Molecular Dynamic Simulation Studies
- 27 March 2025
- journal article
- research article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- p. 1-12
Abstract
The influenza virus causes approximately hundreds of thousands of deaths annually. Coupled with the emergence of drug resistance, there is an urgent need to develop new drugs for the treatment of influenza. Neuraminidase (NA) has long been recognized as a valid drug target for anti-influenza therapy. Herein, in order to identify potential NA inhibitors with novel structures, we employed a structure-based virtual screening strategy to screen a library containing 1.6 million compounds. Based on XP docking score and free energy calculation results, the three compounds E570–1769, K788–4718, and C071–0424 were selected that may have better binding affinity for the NA protein compared to oseltamivir. Amongst, E570–1769 was identified to be the most potential hit. Docking study showed that E570–1769 bound to NA with a binding energy of −10.3 kcal/mol. Moreover, in silico ADME/T studies demonstrated the druggability of E570–1769 was quite well. Furthermore, in vitro assay demonstrated that E570–1769 inhibited the wild-type and H274Y-muatated NAs with IC50 values of 72.6 μM and 229 μM, respectively. Additionally, molecular dynamic (MD) simulation studies were performed to gain a deep insight into the binding modes of E570–1769 in complex with NA. While less potent than oseltamivir, the novel structure of E570–1769 and promising ADME/T properties indicates it as a promising lead for future research.Keywords
Funding Information
- Key Technologies R&D Program of Henan Province (No. 242102311223)
- Medical Science and Technology Key Project of Henan Province (No. LHGJ20220530)
This publication has 34 references indexed in Scilit:
- Computational Screening of Disease-Associated Mutations in OCA2 GeneCell Biochemistry and Biophysics, 2013
- Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor bindingScientific Reports, 2013
- Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinityJournal of Biomolecular Structure and Dynamics, 2013
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceInfluenza and Other Respiratory Viruses, 2012
- Influenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid ReceptorsJournal of Virology, 2012
- Mechanism of 150-cavity formation in influenza neuraminidaseNature Communications, 2011
- Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic reviewJournal of Infection, 2011
- Influenza Hemagglutinin and Neuraminidase Membrane GlycoproteinsJournal of Biological Chemistry, 2010
- The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug designNature, 2006
- The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptorProteins: Structure, Function, and Bioinformatics, 1992